Over the past few years, Mem Sloan Kettering Canc Ctr conducted clinical trials in various solid cancers, including epithelial cancer, ovarian cancer, urothelial carcinoma, and early-stage HER2-positive breast cancer. The gene discussed is ERBB2; the disease is urothelial carcinoma.